首页> 外文期刊>Wiener klinische Wochenschrift >LDL-Cholesterin in der Sekund?rpr?vention: Zielwert-Erreichung unter Lipidsenkern in Praxis und Spital in ?sterreich (ZIEL)
【24h】

LDL-Cholesterin in der Sekund?rpr?vention: Zielwert-Erreichung unter Lipidsenkern in Praxis und Spital in ?sterreich (ZIEL)

机译:LDL胆固醇的二级预防:在奥地利的实践中和医院中降脂患者的目标实现目标(TARGET)

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: A hospital-based screening project (HSP) in Austria found 47% of high-risk patients (LDL-C < 100 mg/dl) and 24% of very high-risk patients (LDL-C < 70 mg/dl) at goal. Separate data for the sexes were not reported. We analyze whether LDL-C goal attainment in patients with manifest atherosclerosis and/or diabetes on stable lipid-lowering treatment differs between private practice and hospital and between men and women. PATIENTS AND METHODS: From September to November 2007, 49 Austrian centers (36 private practice, 13 hospitals) documented vascular morbidity, lipid levels, and lipid lowering treatment in patients with high risk (atherosclerosis or diabetes, n = 978) and very high risk (coronary heart disease and diabetes or acute coronary syndrome, n = 322). RESULTS: 75% and 25% of the 1300 patients were high and very high risk, respectively. LDL-C goals of < 100 and < 70 mg/dl, respectively, were attained by 45.4% and 26.4% of patients (p < 0.001). A similar percentage of patients with very high risk was found in men and women (26.4% vs. 22.9%, NS) and goal attainment was not influenced by sex (high risk: 47.2% (m) vs. 43.8% (w), NS and very high risk: 29.1% (m) vs. 22.4% (w), NS). In patients with high risk, 41.6% treated in private practice vs. 57.9% treated in the hospital were at goal (p < 0.001). In patients with very high risk, 15.9% treated in private practice vs. 45.2% treated in the hospital were at goal (p < 0.001). Lower goal-attainment in private practice occurred despite significantly more intensive lipid intervention and probably reflects higher baseline LDL-C. LDL-C > 100 mg/dl leads to a more aggressive lipid lowering in approx. 70% of patients, irrespective of whether they are treated in private practice or in the hospital. LDL-C between 70 and 100 mg/dl, however, leads to a more aggressive lipid lowering in < 5% of patients, irrespective of whether they are high or very high risk. CONCLUSION: As observed in EUROASPIRE III for other European countries, there is substantial potential for improvement in lipid control in Austrian cardiovascular high-risk patients, irrespective of whether they are treated in private practice or in the hospital.
机译:背景:奥地利的医院筛查项目(HSP)发现47%的高危患者(LDL-C <100 mg / dl)和24%的高危患者(LDL-C <70 mg / dl)在目标。未报告性别的单独数据。我们分析了在私人诊所和医院之间以及在男女之间,在稳定的降脂治疗中,患有明显动脉粥样硬化和/或糖尿病的患者的LDL-C目标达成情况是否存在差异。患者与方法:从2007年9月至11月,奥地利的49个中心(36个私人诊所,13家医院)记录了高风险(动脉粥样硬化或糖尿病,n = 978)和极高风险患者的血管发病率,血脂水平和降脂治疗(冠心病和糖尿病或急性冠状动脉综合征,n = 322)。结果:1300名患者中分别有75%和25%为高风险。患者的LDL-C目标分别<100和<70 mg / dl,分别达到45.4%和26.4%(p <0.001)。男性和女性的高风险患者比例相似(26.4%vs. 22.9%,NS),而目标实现不受性别的影响(高风险:47.2%(m)对43.8%(w), NS和极高风险:29.1%(m)对22.4%(w),NS)。在高危患者中,以私人执业方式治疗的比例为41.6%,而在医院中为57.9%(p <0.001)。在极高风险患者中,以私人执业治疗为15.9%,而在医院治疗为45.2%为目标(p <0.001)。尽管明显加强了脂质干预,但私人执业的目标达成率仍然较低,并且可能反映了较高的基线LDL-C。 LDL-C> 100 mg / dl会导致脂质的侵略性降低,降低幅度约为100 mg / dl。 70%的患者,无论是在私人诊所还是在医院接受治疗。然而,LDL-C在70至100 mg / dl之间会导致<5%的患者发生更具侵略性的脂质降低,无论其高风险还是极高风险。结论:正如在EUROASPIRE III中针对其他欧洲国家所观察到的那样,无论是在私人诊所还是在医院治疗,奥地利心血管高危患者的脂质控制都有很大的改善潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号